Tiziana Life Sciences Stock Forecast, Price & News

Tiziana Life Sciences (NASDAQ:TLSA) Frequently Asked Questions

How has Tiziana Life Sciences' stock been impacted by COVID-19?

Tiziana Life Sciences' stock was trading at $3.95 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TLSA shares have decreased by 77.7% and is now trading at $0.8797.
View which stocks have been most impacted by COVID-19.

Are investors shorting Tiziana Life Sciences?

Tiziana Life Sciences saw a decrease in short interest in the month of December. As of December 31st, there was short interest totaling 67,800 shares, a decrease of 64.0% from the December 15th total of 188,200 shares. Based on an average trading volume of 130,600 shares, the short-interest ratio is presently 0.5 days.
View Tiziana Life Sciences' Short Interest.

Who are Tiziana Life Sciences' key executives?

Tiziana Life Sciences' management team includes the following people:

• Kunwar Shailubhai, CEO, Executive Director & Chief Scientific Officer
• Keeren Shah, Chief Financial Officer
• Vaseem A. Palejwala, Director-Clinical Operations
• Neil Graham, Chief Medical Officer
• Thomas H. Adams, Executive Director & Head-Drug Development

Who are some of Tiziana Life Sciences' key competitors?

Some companies that are related to Tiziana Life Sciences include XBiotech (XBIT), AC Immune (ACIU), Adagene (ADAG), Pyxis Oncology (PYXS), Omeros (OMER), Immuneering (IMRX), ProQR Therapeutics (PRQR), VistaGen Therapeutics (VTGN), Clovis Oncology (CLVS), Viking Therapeutics (VKTX), Nanobiotix (NBTX), Cogent Biosciences (COGT), Sernova (SEOVF), Verastem (VSTM) and Gracell Biotechnologies (GRCL).
View all of TLSA's competitors.

What other stocks do shareholders of Tiziana Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tiziana Life Sciences investors own include Pfizer (PFE), Vaxart (VXRT), Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), Advanced Micro Devices (AMD), Moderna (MRNA), Enterprise Products Partners (EPD), Novavax (NVAX), Dynavax Technologies (DVAX) and Gilead Sciences (GILD).

When did Tiziana Life Sciences IPO?

(TLSA) raised $10 million in an initial public offering on the week of November 19th 2018. The company issued 1,000,000 shares at $9.90 per share. Laidlaw & Company (UK) Ltd. acted as the underwriter for the IPO.

What is Tiziana Life Sciences' stock symbol?

Tiziana Life Sciences trades on the NASDAQ under the ticker symbol "TLSA."

How do I buy shares of Tiziana Life Sciences?

Shares of TLSA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tiziana Life Sciences' stock price today?

One share of TLSA stock can currently be purchased for approximately $0.88.

How much money does Tiziana Life Sciences make?

Tiziana Life Sciences has a market capitalization of $85.60 million.

How many employees does Tiziana Life Sciences have?

Tiziana Life Sciences employs 11 workers across the globe.

What is Tiziana Life Sciences' official website?

The official website for Tiziana Life Sciences is www.tizianalifesciences.com.

Where are Tiziana Life Sciences' headquarters?

Tiziana Life Sciences is headquartered at 3RD FLOOR 11-12 ST. JAMES`S SQUARE, LONDON X0, SW1Y 4LB.

How can I contact Tiziana Life Sciences?

Tiziana Life Sciences' mailing address is 3RD FLOOR 11-12 ST. JAMES`S SQUARE, LONDON X0, SW1Y 4LB. The company can be reached via phone at 44-20-7495-2379 or via email at [email protected].